Compare Equinox Gold Corp. Common Shares (EQX) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinox Gold Corp. Common Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Equinox Gold Corp. Common Shares trades at $11.42 (market cap $12.92B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Equinox Gold Corp. Common Shares and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Equinox Gold Corp. Common Shares pays a 0.47% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Equinox Gold Corp. Common Shares for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| EQX | HALO | |
|---|---|---|
Market Cap | $12.92B | $12.58B |
Volume | 9,067,677 | 2,179,278 |
Sector | Basic Materials | Health |
52-Week High | $18.76 | $115.22 |
52-Week Low | $8.62 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.02B | $14.49B |
Dividend Yield | 0.47% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinox Gold Corp. Common Shares
Equinox Gold is a gold mining company with operations in the Americas. It produces gold and develops additional mining projects.
Read more on EQX →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
